Login

Company Executives

$ Management Team

Dr. Douglas Treco

Chairman of the Board

Chief Executive Officer

Age 66
Compensation $5.299M USD
Sex Male

Mr. Sanjay Subramanian

Chief Financial Officer

Corporate Secretary

Age 48
Compensation $1.033M USD
Sex Male

Mr. Matthew Winton

Chief Operations Officer

Age 46
Compensation $1.549M USD
Sex Male
Directors
9
serving now
Independent
0 of 2
stated in the proxy; 7 not stated
Average tenure
6.6 years
from year joined
CEO also chairs the board
Yes
Douglas A. Treco
Director Age On board Independent Committees Other public boards 2024 pay Source
Sarah Bhagat
39 2019
6 years
Not stated
Audit Committee
None stated $171,966
Reinaldo Diaz
71 2017
8 years
Not stated
Compensation Committee · Chair
Lexeo Therapeutics, Inc. $191,325
Erik Harris
55 2024
1 year
Not stated None stated Denali Therapeutics Inc. $282,286
Axel Bolte
53 2015
10 years
Not independent
Research and Development Committee
None stated $164,093
Robert Hopfner
52 2018
7 years
Not stated
Compensation Committee
RallyBio Corporation $166,950
Edward Mathers
65 2017
8 years
Not stated
Nominating and Corporate Governance Committee
Rhythm Pharmaceuticals, Inc. $170,950
Martin Edwards
69 2017
8 years
Not stated
Nominating and Corporate Governance Committee · Chair
Morphic Holdings, Inc., Verona Pharma plc $185,450
Lynne Sullivan
59 2020
5 years
Not stated
Audit Committee · Chair
Solid Biosciences Inc. $176,950
Douglas A. Treco
67 Not stated Not independent
Research and Development Committee
CRISPR Therapeutics AG Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 29, 2025 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support